Stay updated on Adagrasib in KRAS G12C+ Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the Adagrasib in KRAS G12C+ Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Adagrasib in KRAS G12C+ Solid Tumors Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Added Revision: v3.4.3 to the Record History and removed Revision: v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-11T16:59:35.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    32 days ago
    Change Detected
    Summary
    A new revision entry, v3.4.2, was added to the record history, and the government funding notice banner was removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.9%
    Check dated 2026-02-11T10:24:20.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    The history page now includes a government funding notice and a new revision tag (v3.4.1) while the prior revision (v3.4.0) is removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.9%
    Check dated 2026-02-04T10:11:32.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    UI updates include a 'Show glossary' option, visible color-coded highlights for additions and deletions, and a new revision tag 'Revision: v3.4.0'. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    1%
    Check dated 2026-01-28T04:38:45.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    New revision v3.3.4 was added to the study record history, and revision v3.3.3 was removed, reflecting a minor update to the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T01:45:09.000Z thumbnail image
  8. Check
    82 days ago
    Change Detected
    Summary
    - The changes consist of a new revision entry (Revision: v3.3.3) and removal of the HHS Vulnerability Disclosure and Revision: v3.3.2 from the page footer; these updates do not alter core trial data, eligibility, locations, or other substantive content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-12-23T09:26:57.000Z thumbnail image

Stay in the know with updates to Adagrasib in KRAS G12C+ Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Adagrasib in KRAS G12C+ Solid Tumors Clinical Trial page.